South Korea has announced an $18.9 million contribution to CEPI to strengthen global readiness for future pandemics. The government highlighted that this funding will accelerate vaccine development and support rapid response systems.
The Ministry of Foreign Affairs stated that South Korea’s total contributions to CEPI now reach $70 million. Officials emphasized that this funding is critical for CEPI’s 100-day vaccine development mission and improving global readiness worldwide.
The agreement was signed in Oslo between South Korean Ambassador Seo Min-jung and CEPI CEO Richard Hatchett. Hatchett stressed that pandemics are inevitable and the world cannot afford delays.
He said South Korea’s support demonstrates both financial commitment and scientific leadership. He added that the country’s strong biotechnology and rapid-response capabilities make it a key global partner.
Ambassador Seo praised CEPI’s 2.0 strategy and reaffirmed South Korea’s commitment to close cooperation. She also welcomed Hatchett’s planned visit next year to strengthen joint efforts.
The new funding will support CEPI initiatives until the end of 2026. Afterward, CEPI will launch its 3.0 framework to accelerate vaccine pipelines and expand access for developing countries.
CEPI’s 100-day mission represents a major improvement compared with COVID-19 vaccine rollout. The first vaccines took nearly eleven months to reach the public, revealing weaknesses in research and supply systems.
South Korean officials said the investment aims to prevent higher costs and disruption in future outbreaks. They emphasized that proactive global readiness saves lives and resources.
Experts note that South Korea’s contribution enhances its role as a global health leader. They say the move strengthens international partnerships and emergency preparedness initiatives.
Officials concluded that preparedness is essential. They emphasized that global readiness, coordination, and innovation remain critical to counter future pandemic threats.
